Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization

2.1 / 5 stars · 50/120 Roast Me

MYRIAD GENETICS, INC. Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization

MYRIAD GENETICS, INC. (MYGN) had Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization of $4.60 million as of 2023-12-31, per its 10-K filed 2024-02-28.

Discontinued › Notes

us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedBeforeAccumulatedAmortization · last filed 2024-02-28

  • 2023-12-31: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $4.60M.
  • 2022-12-31: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $7.10M.
Period endHosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization
2023-12-31$4.60M
10-K · filed 2024-02-28
2022-12-31$7.10M
10-K · filed 2024-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92